Ping Ting Chai, LPCA | |
400 S Main St Ste D, Mauldin, SC 29662-2251 | |
(864) 906-2936 | |
Not Available |
Full Name | Ping Ting Chai |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 400 S Main St Ste D, Mauldin, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891465696 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 7775 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ping Ting Chai, LPCA 400 S Main St Ste D, Mauldin, SC 29662-2251 Ph: (864) 906-2936 | Ping Ting Chai, LPCA 400 S Main St Ste D, Mauldin, SC 29662-2251 Ph: (864) 906-2936 |
News Archive
In its Annual World Health Report 2004, the WHO said that more donor funds than ever before, at least $20.5bn (£11.5bn; 17.3bn), are available for AIDS relief in the world's poorest countries, but a huge concerted effort will be needed to get antiretroviral drugs to millions of people who need them before it is too late.
Sapient Discovery, LLC., a structure-guided drug discovery company, announced today that it has entered into a research collaboration agreement with the Helicon Therapeutics, Inc., a San Diego based pharmaceutical company. Under the terms of the agreement, Sapient Discovery will apply its proprietary structural biology platform and expertise to determine the three-dimensional structures for targets of interest to Helicon Therapeutics, Inc.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it will be offering its current inventory of monitors at or below cost to patients through its retail networks as it makes preparations for its next generation of cardiac monitors.
Federal officials report that the Open Payments database, which seeks to make drug and medical device company payments to doctors and hospitals available to consumers, is missing $1.1 billion in payments made between August and December 2013.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
› Verified 4 days ago
Lisa Rist, MA, LPC-I Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 South Main St Suite C, Mauldin, SC 29662 Phone: 864-371-2853 Fax: 866-808-0926 | |
Ms. Amy Lin Campbell, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 S Main St Ste C, Mauldin, SC 29662 Phone: 864-871-1894 | |
Mrs. Eugenia Inez Vigo, LPC-A Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 S Main St Ste C, Mauldin, SC 29662 Phone: 864-553-3083 | |
Dr. Dominique Vedrine, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 213 E Butler Rd # 310, Mauldin, SC 29662 Phone: 864-735-7416 | |
Ms. Michele Blackwell Bennefield, M.S., LPC Counselor Medicare: Accepting Medicare Assignments Practice Location: 400 S Main St, Suite C, Mauldin, SC 29662 Phone: 864-313-9032 Fax: 866-808-0926 | |
Audrey Suzanne Connell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 S Main St Ste C, Mauldin, SC 29662 Phone: 864-735-0842 | |
Ms. April Michelle Chafin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 307 Miller Rd, Mauldin, SC 29662 Phone: 864-297-5044 |